PREFERENCES FOR ADJUVANT CHEMOTHERAPY IN AN ANZGOG SUBSTUDY OF THE PORTEC-3 INTERGROUP RANDOMIZED CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY IN HIGH RISK ENDOMETRIAL CANCER.

被引：0
|
作者：
Blinman, P. [1 ]
Mileshkin, L. [2 ]
Khaw, P. [2 ]
Goss, G. [3 ]
Johnson, C. [4 ]
Capp, A. [5 ]
Brooks, S. [6 ]
Wain, G. [7 ]
Kolodzeij, I. [8 ]
Veillard, A. S. [8 ]
Creutzberg, C. [9 ]
Stockler, M. [8 ]
机构：
[1] Concord Canc Ctr, Concord, CA USA
[2] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[3] Monash Med Ctr, Melbourne, Vic, Australia
[4] Wellington Hosp, Wellington, New Zealand
[5] Calvary Mater Newcastle, Auckland, New Zealand
[6] Auckland City Hosp, Auckland, New Zealand
[7] Westmead Hosp, Sydney, NSW, Australia
[8] NHMRC Clin Trials Ctr, Sydney, NSW, Australia
[9] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2014年 / 24卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCSM-0739
引用
收藏
页码：1482 / 1483
页数：2
相关论文
共 50 条
  • [21] Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high risk endometrial cancer
    De Boer, S. M.
    Wortman, B.
    Bosse, T.
    Powell, M. E.
    Singh, N.
    Hollema, H.
    Wilson, G.
    Mileshkin, L.
    Pyman, J.
    Katsaros, D.
    Carinelli, S.
    Fyles, A.
    McLachlin, C. M.
    Haie-Meder, C.
    Duvillard, P.
    Nout, R. A.
    Verhoeven-Adema, K. W.
    Putter, H.
    Creutzberg, C. L.
    Smit, V. T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 220 - 221
  • [22] Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer
    de Boer, S. M.
    Wortman, B. G.
    Bosse, T.
    Powell, M. E.
    Singh, N.
    Hollema, H.
    Wilson, G.
    Chowdhury, M. N.
    Mileshkin, L.
    Pyman, J.
    Katsaros, D.
    Carinelli, S.
    Fyles, A.
    McLachlin, C. M.
    Haie-Meder, C.
    Duvillard, P.
    Nout, R. A.
    Verhoeven-Adema, K. W.
    Putter, H.
    Creutzberg, C. L.
    Smit, V. T. H. B. M.
    ANNALS OF ONCOLOGY, 2018, 29 (02) : 424 - 430
  • [23] Adjuvant chemotherapy and chemoradiation following surgery for high-risk endometrial cancer
    Narayan, K.
    Rischin, D.
    Quinn, M.
    Goh, J. C.
    Cheuk, R.
    Obermair, A.
    Bernshaw, D.
    McClure, B.
    Milner, A.
    Mileshkin, L. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Adjuvant concurrent chemoradiation followed by chemotherapy for high-risk endometrial cancer
    Ren, Yulan
    Huang, Xiaowei
    Shan, Boer
    Wu, Xiaohua
    Huang, Xiao
    Shi, Daren
    Wang, Huaying
    GYNECOLOGIC ONCOLOGY, 2016, 140 (01) : 58 - 63
  • [25] Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer
    O'Connell, MJ
    Laurie, JA
    Kahn, M
    Fitzgibbons, RJ
    Erlichman, C
    Shepherd, L
    Moertel, CG
    Kocha, WI
    Pazdur, R
    Wieand, HS
    Rubin, J
    Vukov, AM
    Donohue, JH
    Krook, JE
    Figueredo, A
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 295 - 300
  • [26] Adjuvant Chemotherapy for Endometrial Cancer (ACE) trial: A randomized phase II study for advanced endometrial carcinoma
    Egawa-Takata, Tomomi
    Ueda, Yutaka
    Ito, Kimihiko
    Hori, Kensuke
    Tadahiro, Shoji
    Nagasawa, Takayuki
    Nishio, Shin
    Ushijima, Kimio
    Koji, Nishino
    Enomoto, Takayuki
    Kikuchi, Akira
    Honma, Shigeru
    Oishi, Tetsuro
    Shimada, Muneaki
    Takei, Yuji
    Fujiwara, Hiroyuki
    Tanabe, Hiroshi
    Okamoto, Aikou
    Nishio, Yukihiro
    Yamada, Tomomi
    Kimura, Tadashi
    CANCER SCIENCE, 2022, 113 (05) : 1693 - 1701
  • [27] Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial
    Post, Cathalijne C. B.
    de Boer, Stephanie M.
    Powell, Melanie E.
    Mileshkin, Linda
    Katsaros, Dionyssios
    Bessette, Paul
    Haie-Meder, Christine
    Ottevanger, Nelleke P. B.
    Ledermann, Jonathan A.
    Khaw, Pearly
    D'Amico, Romerai
    Fyles, Anthony
    Baron, Marie Helene
    Kitchener, Henry C.
    Nijman, Hans W.
    Lutgens, Ludy C. H. W.
    Brooks, Susan
    Jurgenliemk-Schulz, Ina M.
    Feeney, Amanda
    Goss, Geraldine
    Fossati, Roldano
    Ghatage, Prafull
    Leary, Alexandra
    Do, Viet
    Lissoni, Andrea A.
    McCormack, Mary
    Nout, Remi A.
    Verhoeven-Adema, Karen W.
    Smit, Vincent T. H. B. M.
    Putter, Hein
    Creutzberg, Carien L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 109 (04): : 975 - 986
  • [28] Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
    de Boer, Stephanie M.
    Powell, Melanie E.
    Mileshkin, Linda
    Katsaros, Dionyssios
    Bessette, Paul
    Haie-Meder, Christine
    Ottevanger, Petronella B.
    Ledermann, Jonathan A.
    Khaw, Pearly
    D'Amico, Romerai
    Fyles, Anthony
    Baron, Marie-Helene
    Jurgenliemk-Schulz, Ina M.
    Kitchener, Henry C.
    Nijman, Hans W.
    Wilson, Godfrey
    Brooks, Susan
    Gribaudo, Sergio
    Provencher, Diane
    Hanzen, Chantal
    Kruitwagen, Roy F.
    Smit, Vincent T. H. B. M.
    Singh, Naveena
    Do, Viet
    Lissoni, Andrea
    Nout, Remi A.
    Feeney, Amanda
    Verhoeven-Adema, Karen W.
    Putter, Hein
    Creutzberg, Carien L.
    LANCET ONCOLOGY, 2019, 20 (09): : 1273 - 1285
  • [29] A RANDOMIZED TRIAL OF ADJUVANT CHEMOTHERAPY IN HEAD AND NECK-CANCER
    TAYLOR, SG
    APPLEBAUM, E
    SHOWEL, JL
    NORUSIS, M
    HOLINGER, LD
    HUTCHINSON, JC
    MURTHY, AK
    CALDARELLI, DD
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (05) : 672 - 679
  • [30] ADJUVANT CHEMOTHERAPY - THE RESULTS OF A RANDOMIZED TRIAL IN BREAST-CANCER
    STEWART, HJ
    FORREST, APM
    RODGER, A
    DUNCAN, W
    LANGLANDS, AO
    GUNN, JM
    SONGHORABADI, S
    BRITISH JOURNAL OF SURGERY, 1983, 70 (11) : 687 - 687
12345